Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
about
Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review.Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort studySex differences in the beneficial cardiac effects of chronic treatment with atrial natriuretic Peptide in spontaneously hypertensive rats.The evolving role of nesiritide in advanced or decompensated heart failure.Diagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction.Prospective clinical evaluation of an ELISA B-type natriuretic peptide assay in the diagnosis of congestive heart failure in dogs presenting with cough or dyspnea.Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine.Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.Utility of natriuretic peptide testing in the evaluation and management of acute decompensated heart failure.Practical application of natriuretic peptides in paediatric cardiology.In-hospital and long-term outcomes of congestive heart failure: Predictive value of B-type and amino-terminal pro-B-type natriuretic peptides and their ratio.Increased urinary excretion of uroguanylin in patients with congestive heart failure.Origins of cardiac dysfunction in cirrhosis.The value of (NT-pro) BNP in the diagnosis, prognosis and treatment of congestive heart failure.Brain natriuretic Peptide production and secretion in inflammation.Period3 VNTR polymorphism influences the time-of-day pain onset of acute myocardial infarction with ST elevation.Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure.Clinical implication of atrial and brain natriuretic Peptide in coronary artery bypass grafting.N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states.Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms.Plasma adrenomedullin relation with Doppler-derived dP/dt in patients with congestive heart failure.Recent advances in point-of-care testing for natriuretic peptides: potential impact on heart failure diagnosis and management.Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration.Circulating levels of cardiac natriuretic hormones measured in women during menstrual cycle.Adrenomedullin plasma levels predict left ventricular reverse remodeling after cardiac resynchronization therapy.Comparison between immunoradiometric and fluorimetric brain natriuretic peptide determination in patients with congestive heart failure.The use of B-type natriuretic peptide (BNP) to distinguish heart failure from lung disease in patients presenting with dyspnea to the emergency department.Determining the cause of dyspnoea: linguistic and biological descriptors.Practical implications of current natriuretic peptide research.Comparison of markers of circulating blood volume in hemodialysis patients.B-type natriuretic peptide (BNP) in patients undergoing mitral valve surgery.Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis.NT-proBNP in normoalbuminuric patients with Type 2 diabetes mellitus.Influence of sample matrix and storage on BNP measurement on the Bayer Advia Centaur.Difficult cases in heart failure. Novel diagnostic markers in heart failure: an emerging paradigm shift?Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones.
P2860
Q33227738-D0F0D17E-74DB-4C07-BF6B-EE18D9E3A9D4Q33699467-0B47D79E-5B07-46CB-8E30-D693A6D3F173Q34951017-881EF7EA-B3A4-4850-8D91-4E4795C4D47CQ35574016-5BFDF6AC-3AF0-4153-ABC9-EE8051E00173Q36732168-520F5C04-09E9-4F89-B518-DA04A148653FQ36788204-3BA444BC-34BA-467A-B9F2-E07C49B4FDCBQ37207285-5199C03E-A81E-4315-99B9-052CFE92393EQ37229555-4033D911-45F1-4366-868D-1FBC6D606BB9Q37277937-9AB239F7-D1D9-4A66-BF73-71537DD75A5EQ37440830-F8A8E184-2488-429E-AB99-EA9E450A4448Q37748955-44682EDC-71EC-42BA-9CBD-3FE1C1348EA9Q38623581-ED2591CA-90F2-4F5F-AF5A-6D6142F0053BQ40901382-C39E5249-ECDD-438D-9842-D5B62D03BD4EQ41914715-53E8B9C1-A851-41C4-88F2-784EBD6F1751Q42340726-02BFF0EA-65AC-4D48-AADE-A96AC7AD3E81Q42392980-8B288FAD-3405-45A2-B999-CBC63C6094D8Q44060571-E299D91C-3722-470E-91AD-A4E71DC1DAD0Q44426645-CB4ACD4C-F7B5-48CA-8B8B-665A2EF5256DQ44454120-3AC294D0-619F-43CB-BE61-94CA90F52262Q44695303-9E6EBBDD-CD3C-4061-B96D-62F69CEB1E06Q44776909-77353DEC-A019-4849-A9CB-EBC90EA081EDQ45122720-6857978D-8ACE-47D3-B97D-D2B9335121E5Q46335976-6671DF4E-3BA0-49C8-9C67-A4FB6C8ECA9AQ48230690-F2659F59-ED6C-487F-AEEC-3F6F898EB148Q48256111-5D8F4822-AB04-4278-A6E5-EF6D535A5D78Q48272156-AAF30119-FC1A-44B7-B31F-31DDADEDA8EBQ48304875-57ACB60B-6ACB-4CD6-AB77-5A337ACDD77FQ48375055-E859EA28-7E50-4D04-ADEC-B4B8CB753571Q48444712-5F9BD6BB-792E-441C-81FA-3B98473442ACQ48624965-462FF9C7-1F1B-4C8C-9292-61159243EE93Q48764379-EB76F408-C772-43EF-8930-EED239D279B5Q48924793-90A1878A-347E-4FA2-AF92-D34FBF27EA65Q48966952-BE6B047E-D589-4F07-A984-2FBA31DA0451Q49132717-C26F5C68-BC92-40A2-81B5-5A2C64E0AB94Q53027344-FCFCC1B5-8461-49F2-827A-831605B456B4Q53674298-52F36DE3-E7E4-43AF-B65F-8916D23E674FQ53998579-7415079A-0864-4245-AE77-921F740DABD6
P2860
Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Circulating levels of cardiac ...... rent degrees of heart failure.
@en
Circulating levels of cardiac natriuretic peptides
@nl
type
label
Circulating levels of cardiac ...... rent degrees of heart failure.
@en
Circulating levels of cardiac natriuretic peptides
@nl
prefLabel
Circulating levels of cardiac ...... rent degrees of heart failure.
@en
Circulating levels of cardiac natriuretic peptides
@nl
P2093
P2860
P356
P1476
Circulating levels of cardiac ...... rent degrees of heart failure.
@en
P2093
C Manfredi
L Sabatino
M G Del Chicca
P2860
P2888
P304
P356
10.1007/BF03347297
P577
1998-03-01T00:00:00Z